Study included in this review has to meet all of the following inclusion criteria in the PICOS order:

population: patients with CHF and COPD;

intervention group (group 1): routine treatment with trimetazidine and bisoprolol;

comparison group (group 2): routine treatment without trimetazidine and bisoprolol;

outcome measures: all-cause mortality and hospitalization for cardiac or/and respiratory causes; left ventricular structure and function; and functional scores;

study design: randomized controlled trial or observational study.

Biomechanical studies, in vitro studies, review articles, techniques, case reports, letters to the editor, and editorials are excluded.

注意:以上内容是从某篇研究文章中自动提取的,可能无法正确显示。



Q&A
请登录并在线提交您的问题
您的问题将发布在Bio-101网站上。我们会将您的问题发送给本研究方案的作者和具有相关研究经验的Bio-protocol成员。我们将通过您的Bio-protocol帐户绑定邮箱进行消息通知。